Revere Asset Management »

Vaneck Vectors Pharmaceutical etf shares owned by Revere Asset Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Revere Asset Management from 13F filings

Historical chart of Revere Asset Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Revere Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Revere Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 173k 90.36

More positions owned by Revere Asset Management

Spdr Series Trust Portfolio S&p500 (SPLG)
Proshares Tr Pshs Ult S&p 500 (SSO)
Proshares Tr Ultrpro S&p500 (UPRO)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Robinhood Mkts Com Cl A (HOOD)
Doordash Cl A (DASH)
Palantir Technologies Cl A (PLTR)
Mp Materials Corp Com Cl A (MP)
Nebius Group Shs Class A (NBIS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Coreweave Com Cl A (CRWV)
Snowflake Com Shs (SNOW)
Bloom Energy Corp Com Cl A (BE)

View all positions for Revere Asset Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Jane Street
Revere Asset Management
Adamsbrown Wealth Consultants
Bnp Paribas Arbitrage, Snc
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf